Please assess the completion status of the following clinical trial:

Trial Title: Intraperitoneal Aerosol Chemotherapy in Gastric Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* age above 18 years~* written, informed consent~* presence of peritoneal carcinomatosis~Exclusion Criteria:~* language barrier~* parenchymal metastases~* unability to undergo laparoscopy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Intraperitoneal Chemotherapy (Type: EXPERIMENTAL): Patients will receive doxorubicin 1.5 mg/m2 body surface in 50 ml NaCl 0,9% and cisplatin 7.5 mg/m2 in 50 ml NaCl 0,9% q 4-6 weeks, applied intraperitoneally as pressurized aerosol chemotherapy. Duration of treatment will be 3 single doses in 6 weeks intervals, thus the duration of treatment is 18 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).